5th International Symposium on Corneotherapy

Planning is well underway for the 5th International Symposiusm on Corneotherapy.

skycity hotel aucklandThe event is to be held at the Sky City Complex in Auckland, New Zealand over 12-14th January 2018.
In addition to full schedule of events, we have arranged a dinner on the Saturday evening in the Obit Restaurant, rotating once every hour at 328m above the ground. It is the second tallest freestanding structure in the southern hemisphere. The views are breathtaking.
Attendance fees for the event include welcome dinner, (12th) Obit dinner (13th) and refreshments (inc lunch) for the entire event.
I.A.C. members: €375.00 (US$425.00, NZ$600.00)
Non I.A.C. members: €500.00 (US$565.00, NZ$800.00)

The theme of the symposium is the Microbiome and Corneotherapy, a subject that is of increasing interest as we see more compromised skin conditions in clinic that are related to the disruption of the microbiome in some form. The presenters for the syposium were chosen to provide a valuable overview of not just the skin microbiome, but the microbiome of the body in general and the challenges we face in maintaning its homeostasis in the modern world.


Confirmed presenters in schedule order:

Roediger 150pDr. Ben Roediger: Department head, Centenary Institute, NSW, Australia
Dr Roediger is currently head of the Skin Inflammation Group within Professor Wolfgang Weninger’s Immune Imaging Laboratory at the Centenary Institute, NSW, Australia.
Dr. Roediger is an acknowledged expert in cutaneous immunology, having co-authored 13 primary papers and six reviews on the topic, three as corresponding or co- corresponding author.
We are honored to have Dr. Roediger speak about Skin Inflammation and the microbiome, as well as Immune Imaging.
More information here.


Wiles 150pDr. Siouxsie Wiles: Senior Lecturer, University of Auckland, New Zealand.
Dr Wiles describes herself as a microbiologist and bioluminescence enthusiast. Head of the Bioluminescent Superbugs Lab at the University of Auckland, Siouxsie combines her twin passions to understand infectious diseases. In a nutshell, Siouxsie and her team make nasty bacteria glow in the dark. Siouxsie is also interested in demystifying science for the general public and raising awareness of the growing threat of antibiotic-resistant superbugs.
She is a blogger and podcaster, as well as being a regular science commentator for Radio NZ’s Nine to Noon program. Siouxsie has also teamed up with Australian graphic artist Luke Harris, to make short animations describing nature’s amazing glowing creatures and the many uses of bioluminescence in science. 
Dr. Wiles lecture will be on AMPs - fighting against facultative pathogenic microbes. 
More information here

Cameron smith 150pProfessor David Cameron-Smith: Associate Director, Liggins Institutre, University of Auckland, New Zealand
Dr Cameron-Smith obtained his Ph.D. in nutritional biochemistry from Deakin University, Australia. He undertook postdoctoral training at the Royal Prince Alfred Hospital, Sydney, investigating endocrine disturbances and lipid metabolism in obesity. Returning to Deakin University, he established a clinical research programme focusing on the dynamic gene and signaling responses to nutrition and exercise.
His appointment to the Chair in Nutrition at The University of Auckland complements the diverse nutritional research interests within the Liggins Institute and adds to the strategic growth of the University’s trans-disciplinary Food and Health Programme.
Current research Understanding how nutrition regulates genes and the biochemical pathways that are essential for optimal human health. Research is directed towards understanding:
• The importance of nutrition in the maintenance of optimal health in an ageing population.
• The impact of nutrition in regulating the function of muscles to promote muscle growth and minimize fat gain.
• Where nutrients go after a meal and how these nutrients control genes and regulate metabolism.
Professor Cameron-Smith will be lectureing on The ‘human gut microbiome at its relationship to human health’.
More infomation here. 

Chia yu 150pProfessor Chu Chia-Yu, MD, PhD. National Taiwan University, Taipei, Taiwan
Prof Chu is a dermatologist & toxicologist and Associate Professor, Department of Dermatology, National Taiwan University, Taipei, Taiwan. Prof Chu was a former presenter at the 4th Symposium, and his topic was the use of DMS base cream with fluticasone propionate (FP) as a treatment for atopic dermatitis. We look forward to listening to Professor Chu again when he shares his knowledge on Skin the Microbiome and Dermatology.
More information here. 

Rodger 150pCraig Rodger; The Chef. Founder of NZ's first LCHF restaurant, Auckland, New Zealand.
Co-Author of the book, ‘What the Fat”?  Craig Rodger cooking philosophy is Living foods and how to make them. Chef Rodger is a classically trained chef who spent eight years cooking in fine-dining restaurants, including Michelin- starred establishments in his native Scotland. Craig felt compelled to research and incorporate a different approach to eating and cooking and has a real passion for stripping away carb-laden fillers and using nutritionally dense ingredients as the foundation of culinary excellence.
Craig is going to lecture on “living foods” and how they affect the gut microbiome.

Lautenshlager 150pDr Hans Lautenschläger, Ph.D. Organic Chemist, Cologne, Germany.
Dr. Lautenschläger is a internationally respected organic chemist and pharmacologist with vast experience in the development of formulations and products designed for the skin. Research & Development under his guidance for a number of German organisations has produced novel pharmaceutical actives for lipid metabolism disorders, inflammation and heart, blood and circulation diseases. His interest in phospholipids and their application in treating skin barrier disorders have put him in the forefront of innovative design of skin care products primarily employed in applied Corneotherapy.
More information here.

Robertson 2 150pRachel Robertson: NZARBP Vice President & Entrepreneur, Wellington, New Zealand.
Rachel is a multi award winning business owner and skin care practitioner who has been in the Beauty Therapy industry since 1998. She has CIDESCO and CIBTAC qualifications and has an initmate understanding of the skin care industry. In addition to her roles as vice president, PR marketing and NZ Beauty awards portfolio of the New Zealand Association of Registered Beauty Professionals, (NZARBP) Rachel is the creator and director of a New Zealand manufactured skin care product. Rachel has first-hand knowlede of the challenges in creating a progressive skin care line that avoids the use of popular, but non-physiological ingredients. Along with public speaking, Rachel also writes for both industry and public magazine and websites.
Rachel's topic for the symposium will be on the Influence of preservatives on the microbiome of the skin. 
More information here.

Fleming 150pTrudy Fleming: ASLMS fellow, Light based hair reduction expert, Melbourne, Australia.
Ms Fleming has been in the hair removal and skin treatment industry for 40 years, and kept at the forefront of her profession by constantly furthering her education. Since 2002 she has trained therapists and practitioners in both laser safety, treatment techniques, hair removal, pigment removal, vascular treatment, tattoo removal and skin rejuvenation in its many forms.  Trudy has been a guest speaker at numerous conferences over the years in the USA (ASLMS), UK (BMLA), New Zealand (Beauty NZ) and of course all around Australia.  
Trudy will join us in 2018 to share her vast knowledge. Her topic will be “Does laser affect the microbiome”? The answer to this question is one that all leading laser specialists and Corneotherapists need to know.  More information here.  

Lanzedorfer yu 150pDr. Ghita Lanzendörfer-Yu, PhD: Freelance Online editor, Germany
Dr Lanzendoerfer-Yu, PhD has a PhD in inorganic chemistry and has worked in many R&D roles with major German personal care companies including Beiersdorf AG and Schwan STABILO Cosmetics GmbH & Co KG.
Her experience as a lab manager and with projects that included dermatological formulations, make-up formulations, pigment dispersions, emulsion, gel and stick technology, trend analysis, technology scouting and IP rights.
Since 2011 she has been writing as a columnist for the cosmetic platform www.pinkmelon.de, having published more than 140 articles on all kind of cosmetic topics.
Today she is a certified online editor and offering services in generating content / in-house training/publications on cosmetics, raw materials, methods, formulations. Since 2016 she has been operating her blog: www.dejayu.de.
Many of you will remember Dr. Ghita and her inspiring lecture at our last symposium in Germany. We are delighted that Dr. Lanzendoerfer-Yu will be joining us again in NZ and she will be speaking on a subject dear to all of us here in the Antipodes: Ethnic skins, sunscreens and how chemicals affect the skin microbiome. This is a subject that creating some discussion throughout the industry and i'm sure we all look forward to listening to Dr. Lanzendoerfer-Yu again.

Serbon 150pRene Serbon: Independant consultant and educator, Penticton, Canada. 
Ms Serbon is CIDESCO and CIBTAC qualified skin treatment practitioner with many years of experience with the Pastiche Method of skin analysis, and is a Pastiche recognized education provider. In addition to her extensive clinical expertise with skin diagnosis and treatment strategies, she is a consultant to the industry in the areas of practice management and developing best practice procedures and protocols. Rene serves on the education board of the International Association for Applied Corneotherapy, where she helps develop multi-centric programs for individuals interested in learning advanced, non-invasive skin treatment techniques. Rene will be speaking on the Corneotherapy subject; Re-establishing the skin microbiome with corneotherapy.
More information here.

Full symposium schedule can be viewed here.
Please register your intention to attend the symposium here.

Review: 4th Symposium

The 4th Symposium on Corneotherapy 2016

IAC boardThe board of the I.A.C. are pleased to announce that the 4th Symposium on Corneotherapy held over the weekend of the 6th-8th May 2016 in Cologne, Germany was an outstanding success, bringing attendees from across the globe to hear a roster of top speakers discuss all things Corneotherapy.
This year's symposium had the theme Adjunct Corneotherapy and so the presentations covered many interesting topics.

 


The I.A.C. board (from left) Margaret Walsh-Shearer, (Secretary) Florence Barrett-Hill, (Madame Chair) Hans Lautenschläger, (Vice Chair) and Marek Harder. (Treasurer) 

At the reception dinner on the evening before the symposium, the group welcomed both our new and existing members to the event. Many had not seen each other since the last event in Taiwan in 2014 and it was great to see associates and friends reacquaint themselves. A lovely meal followed and we were treated to musical entertainment by a string and piano trio.

 

Group 2 16

Group 1IAC speaker 2 

 

 

 

 

 

The following morning we gathered in the auditorium for the morning session. After the opening addresses by Madame Chair Florence Barrett-Hill, Vice Chair, Dr Hans Lautenschläger, and Secretary Margaret Walsh-Shearer, the event first speaker took the podium.

 

Ghita 16Dr Ghita Lanzendörfer-Yu, PhD began the proceedings with a informative and entertaining presentation on the changes in both the understanding of the skin and the ingredients in skin care products over the last 150 years.
Dr Lanzendörfer-Yu took the audience on a journey through from the earliest occlusive formulations through the understanding of the skin barrier and bilayers, and on to skin biotypes and the future of skin care.
We were taken on a review of the composition of NMF and the skin barrier lipids, reinforcing the role of ceramides and how their absence can be correlated to pathogenic skin conditions.
We also learned about the genetic and pathogenic factors associated with atopic dermatitis and psoriasis.
Dr Lanzendörfer-Yu concluded with a very valid statement; with what we know about the skin microbiome serving as the first barrier of our skin, and what we understand about where dietary or bacterial metabolites intersect with the immune system, both our skin cleaning/caring routines and quality of food intake should be questioned in future. There were many questions from attendees, and this capped off a truly engaging and compelling presentation to kick start the symposium.

Chrisiane 16Our next speaker was Christiane Uhl , a skin diagnostic device expert from local Cologne based Courage & Khazaka, a world leader in skin diagnostic equipment.
Christiane began with why the modern skin treatment therapist needs to have detailed knowledge about skin types and influences on skin conditions to be used in conjunction with a detailed consultation procedure, ideally using some form of skin diagnostic devices.
Christiane explained the industry standard measurement techniques used in skin diagnostic procedures for ascertaining skin health and condition, and the various technologies employed.
We learned about the importance of ascertaining skin moisture and sebum levels, and the health of the acid mantle along with determining skin's biological age by examining skin elasticity.
We also learned about special cameras used to determine degrees of hyper pigmentation and rosacea.
Christiane concluded with a overview of the software used in conjunction with the various measuring technologies to obtain a record of the skin's health at a particular time, and documenting any improvements while using the data for comparative studies.

Christel 16After a short break, the board welcomed Professor Christel Muller from the Technical University of Braunschweig, Germany, to the podium. Prof Muller's topic was about Saponins. Not simply about their use in skin care, but a enlightening education about their uses and properties far beyond their more commonly understood detergent-like properties; from antioxidant to drug delivery systems.
Prof Muller began by explaining what saponins are, their various sources and their properties.
We learned about their pharmacological and immunological effects including wound healing, antiviral, antimicrobial and antifungal activity, as well as the anti-inflammatory properties of some types.

Dr Muller concluded by telling us about the promising activity of some saponins anticancer activity, and their effects for the development of adjuvant vaccines. A truly eye-opening and informative presentation. 
 

Hans 1 16The I.A.C.'s own resident organic chemist, Dr Hans Lautenschläger, PhD was next.
Dr Lautenschläger's topic was a subject he knows well; Nanodispersions. (Also known as Nanosuspensions, nanoemulsions, microemulsions, liposome's and vesicles) Dr Lautenschläger began with an overview of the efficiency of nanodispersions when compared to pharmaceutical active agents, and consequently their ideal role as a base for cosmeceuticals. We learned how the use of nanodispersions opens a whole new way of applying skin care formulations with greater efficiency and comfort, and the fact a majority can be biodegradable. He explained how nanodispersions are the perfect choice for some individually tailored skin preparations.
Dr Lautenschläger also addressed the perceived negative aspects; that of systemic toxicity of non-degradable nanoparticles. He did point out that regardless of their biodegradability, nanodispersions offer high bioavailability at low doses of active agents with an irritation threshold lower than for conventional emulsions. 
We learned that nanodispersions allow a reduction or even elimination of additives such as emulsifiers, spreading substances and penetration enhancers, making formulation much simpler, less prone to irritation and rise to the "wash out" effect. Another important factor we learned that because the nanodispersions are produced in sterile forms, the reliance on preservatives is reduced or eliminated.
Finally, Dr Lautenschläger reviewed examples of active agents used on a variety of skin conditions, their nanodispersion type and action. An interesting and informative presentation.

Chia Yu 16Our last presenter before lunch was Professor Chia-Yu Chu, MD,PhD from the National Taiwan University Hospital. Prof Chu was a previous presenter at the 3rd Symposium, and his topic was the use of DMS base cream with fluticasone propionate (FP) as a treatment for atopic dermatitis.
Prof Chu began with an overview of the disorder, and the established treatment solutions being topical corticosteroids of different strength, focusing on immune intervention.
Prof Chu explained the creation of a study using a 0.05% concentration of FP in a DMS base compared to compared to FP in conventional bases such as propylene glycol, sorbitan sesquioleate, wax, paraffin etc.
he explained the reason DMS was chosen was that the goal was to make the structure and composition resemble the natural skin barrier. The study was to determine the efficacy of the FP when in a more physiological carrier.
The study is to be over a four week period for each subject, with clinical evaluations in conjunction with measurements of SC hydration and TEWL.
Prof Chu explained the study was ongoing, with the results and conclusions to be presented at the next I.A.C. Symposium.

Burkhard 16Following our delicious lunch, (Thank you to the Hyatt team) we took our places for the afternoon session, with Prof Burkhard Kleuser, PhD, our first presenter. Prof Kleuser is from the University of Potsdam, Germany.
Prof Kleuser's presentation was on the subject of Sphingolipids and their influence on skin barrier and cornification disorders.
Prof Kleuser began with an introduction to Sphingolipids, explaining their structure and chemistry and how they are essential structural components of the skin. From this we learned that ceramides play an important role in the formation of Sphingolipids, and consequently ceramides are essential for epidermal barrier function.
We were treated to a detailed and highly visual explanation of the different ceramides and Sphingolipids, and also that Sphingolipid derivatives such as ceramides and sphingosine-1-phosphate (S1P) influence many aspects of the skin including keratinocytes and dendritic cells of the immune system.
Prof Kleuser explained the relationship between Sphingolipid disfunction and skin disorders such as atopic dermatitis, revealing the mechanisms of the disfunction.
He concluded by explaining that therapeutic approaches based on topical administration or systemic delivery of sphingolipid-metabolites or sphingomimetic molecules may be beneficial in avoiding pathophysiological conditions of the skin.
Prof Kleuser's presentation was both spirited and informative, and a brisk start to the afternoon's proceedings.

Martin 16Next was Dr Martin Weisser, PhD, a cosmetic chemist from local Manufacturer KOKO GmbH.
Dr Weisser's subject was safety reports; specifically the requirements for corneotherapeutic products.
First, we learned about the legislation that required cosmetics manufacturers in Europe to implement a comprehensive safety assessment to ensure that the product is safe for human use before it was placed on the market.
Dr Weisser then explained the structure, requirements and parameters of the safety report required for each product.
We discovered that there are many complex equations and formulas used in conjunction with testing procedures to determine the safety. We learned that many factors are taken into consideration including toxicological safety factors, physicochemical stability, microbiological safety, metabolic degradation, percutaneous/dermal absorption routes and much more.
We also heard about the calculations used to determine such parameters as Systemic Exposure Dose (SED), Margin of Safety (Mos), No Observed Adverse Effect Level (NOAEL)
Dr Weisser's presentation left us confident that the reputation of true corneotherapeautic products can be assured when they are manufactured and tested to the same standards as pharmaceutical products.

Imke 16Our final presenter for the day was Dr Imke König, MD, the spa director of the Luxury Spa Schloss Elmau, Germany. Dr König's presentation was a subject close to the heart of many of the I.A.C's membership; Transparency beyond marketing and advertising claims, and the understanding of the INCI lists of cosmetic ingredients.
Dr König began with introducing us to the LOHAS consumer,(Lifestyles of Health and Sustainability) and their needs that makes the role of the cosmetics/skin care seller or skin treatment service provider more meticulous. This is because they seek far more information about the skin care products they use and the treatments they undertake than normal consumers.
We learned that in order to satisfy this growing sector of the market that we need to understand more toughly the INCI ingredients in skin care and cosmetic products, particularly when there is so much misinformation from manufacturers and marketers.
Dr König explained the various regulations in different parts of the world and consequently the dilemma of skin care products containing ingredients banned in other parts of the world. She explained the various approaches people use to try to obtain correct and valuable information about the INCI list. We learned about indentifying ingredients such as paraffin's, silicones alcohols, checking colorants, allergens, sensitizers, preservatives, surfactants, chelating agents etc.
Dr König's presentation was common ground for many of the attendees and was well received, with many questions from both attendees and other presenters.

After a short break, the I.A.C's  general Assembly commenced. A full report including the minutes will be available to members next month.

frueh 16The first day of the program concluded at 6.30pm with the group taking advantage of the pleasant spring evening to take a short walk across the landmark Hohenzollernbrücke bridge for a dinner in the spacious cellars of the iconic Früh am Dom restaurant, home of the famous Kölsch beer.

 

 

 

 

 

 Day Two 

Day two of the Symposium began with a brief address and review of the proceedings so far by I.A.C. Secretary, Margaret Walsh-Shearer.

Markus 16Our first speaker for the day was Prof Markus Böhm, MD, from the department of dermatology, University of Münster, Germany. Dr Böhm's presentation was on the subject of Vitiligo, a condition of significance for the skin treatment therapist memberhip who encounter this condition in their practices.
Dr Böhm commenced with a overview of the types of vitiligo, the prognosis and pathogenesis of the condition, briefly exploring several current hypotheses that have disclosed the presence of mutations in several key regulator genes controlling immune functions in non-segmental vitiligo.
Dr Böhm explained that with current knowledge, the cause of vitiligo is best summarized as a convergence ("convergence theory“) of several pathobiologic key events (most of which are outlined above) that make melanocytes vulnerable to cellular stress (e. g. induced by biochemical, metabolic, neuroendocrine abnormalities).
As a consequence an immune attack is mounted that will lead to destruction of epidermal melanocytes resulting in various degrees of depigmentation depending on the activity of the disease.
Dr Böhm went on to discuss the various treatments currently employed, but made special note of treatments employing UVB at 308nm with topical corticosteroids or calcineurin inhibitors, and UVB at 311nm in conjunction with Afamelanotide, a superpotent melanocortin peptide. A fascinating and informative start to the morning.


Florence 16Following Prof Böhm was our Madame Chair of the I.A.C, Florence Barrett Hill, an independent dermal science educator from New Zealand. Ms Barrett-Hill's presentation was on another topic of importance to the membership- Rosacea.
The presentation began with an overview of the different types of Rosacea and their physical appearance, noting that was perhaps one of the most misdiagnosed dermotoses of adults.
We learned that rosacea can be safely classified as skin barrier disorder, with the now understood defence systems of the innate immune system being triggered by a variety of agents.
Ms Barrett-Hill walked us through the leading causes, the biophysical events occurring and explaining how each plays a role in the development of the condition. We learned about the various receptors, enzymes, peptides and hormones responsible for the development of the condition.
She then expanded on the four different sub-types of rosacea and variants. Ms Barrett-Hill concluded with best practice approaches to treatment pathways, with specific emphasis on maintaining client/patient compliance to their personal role in the treatment program.

 

Mattias 16After a short refreshment break, Dr Matthias Aust, a plastic and cosmetic surgery specialist from Bad Wörishofen, Germany, who delivered his presentation on the subject of dermal needling. This was another subject of great interest to the skin therapist sector of the membership.
Dr Aust began with be explaining to the members that as the demand for less invasive, highly effective cosmetic procedures grows, plastic surgeons must explore and develop new treatment options; with particular emphasis of the reduction of scar formation.
We learned that transforming growth factors (TGF) play a major role in the formation of scars, with TGF -β appearing to promote minimal scarring during the regeneration and wound healing process.Dr Aust then went on to explain that percutaneous collagen induction (dermal needling)is a modality that brings us closer to this ideal of regeneration of the skin because of the expression of the TGF -β as part of the process.
Dr Aust detailed the best practice procedure and equipment , post operative care, and advantages/disadvantages.
He then showed us many examples of various treatments across different areas of the body, discussing results, limitations and complications. Dr Aust then explained the rationale for the adjunct application of vitamins A and C topically post needling; concluding that since the introduction of percutaneous collagen induction therapy almost 20 years ago, it has evolved into a simple and fast method for safely treating wrinkles and scars as opposed to ablative laser treatments. There were many questions from the membership and fellow presenters, and much post event discussion on this topic.

Sofia 16Next up was Dr Sofía Ruiz del Cueto, from Madrid, Spain. Dr Ruiz del Cueto, who is a dermatologist and plastic & aesthetic surgeon was speaking about how corneotherapy can help as an adjunct to fractional laser treatments.
Dr Ruiz del Cueto began with a brief overview of fractional ablative lasers and the difference with conventional types. She then outlined the key factor in the good outcome is the skin's recovery and good wound healing processes, reducing side effects such as PIH and downtime.
Dr Ruiz del Cueto noted in her experience that corneotherapy had proven to be an essential tool in her clinics practices as a follow up protocol, as they sought solutions to reduce the TEWL post treatment.
Dr Ruiz del Cueto commented that during the last 12 months the clinic had introduced phosphatidylcholine based cosmetics as a laser follow up protocol , resulting in a 35% reduction in down time and patient compliance and satisfaction increased by 60%.
There were many questions from the members, and a reinforcement of the value of corneotherapeutic approaches as adjunct therapies both pre and post ablative and non ablative methodologies.

 

Alext 16Our final speaker for the symposium was Alexandra J. Zani, an independent educator and author from the United States. Ms Zani's topic was a review on studies where adjuvant corneotherapy has been used in treatments and interventions from lasers to oncolgy aesthetics.
Ms Zani began with a brief explanation of the term adjuvant refers to in relation to medical and surgical procedures, and that is has been shown to be highly beneficial when administered for pre and post skin care such as when combined within the context of plastic or reconstructive surgery.
Ms Zani then outlined the various procedures typically adapted to each specific intervention, including Pre-post surgery, wound care, and post pigmentation treatments. She then shared some thought-provoking observations concerning trends that promote a greater perspective when it comes to aging, health and longevity, and a global paradigm shift when it comes to wellness and embracing a more preventative approach to treating skin conditions and health issues.
Ms Zani concluded by briefly speaking about the growing change moving from conventional and traditional care of health into a more proactive philosophy of integrative medicine and philosophies of prevention; a shift in which corneotherapy can play a role.


The symposium concluded with thanks and closing statements from madame Chair Florence Barrett-Hill and vice chair, Hans Lautenschläger; in which the announcement that the 5th symposium on corneotherapy would be held in Auckland, New Zealand in January 2018.
Special thanks go to our sponsors; (below right) Pastiche Training, Metrodermo SL, KOKO Kosmetikvertrieb GmbH & Co, Dermal Sytems inc, ID skin care Ltd, High Grade Pharmeceutical Ltd, VIP Koreana, DMS International Ltd, and Megavalis UAB for their financial and material support. Without our sponsors, these events would not be possible.

Promo 3IAC sponsors

 

 

 

 

 

 

 

 

The post event social gathering was a leisurely boat ride down the Rhine to the historic town of Zons, where we enjoyed a guided tour before boarding our boat back to Cologne where we indulged in a sumptuous buffet on our way.

Group 5

Zons 1

 

 

 

 

 

 

 

 

 

Boat 1river 1 

 

 

 

 

3rd International Symposium on Corneotherapy 2014

The 3rd International Symposium on Corneotherapy 2014 was a great success!
Venue for the event was the Ambassador Hotel, Kaohsiung, Taiwan between 17-19 November 2014

 

The guiding theme for the symposium was The Compromised Skin & Corneotherapy and featured presentations from Prof Lars Norlen, (Sweden) Dr Hiroshi Ikeno, (Japan) Dr Tzu-Kai Lin, (Taiwan) Dr Chia-Yu Chu, (Taiwan) Walter Arkesteijn, (Netherlands) Dr Pin-Chi Chiu, (Taiwan)  Dr Hans Lautenschlager, (Germany) Florence Barrett-Hill, (New Zealand)  Rene Serbon, (Canada) and Kathryn Mazierski. (United States)

The event attracted over 85 participants from 14 countries around the world.

 

 

Some of the participants who attended the 3rd Internationalsymposium on Corneotherapy 2014

 

Read more: 3rd International Symposium on Corneotherapy 2014

The 2nd International Corneotherapy Symposium

The 2nd International Symposium on Corneotherapy 2013 was held over the week of May 10-17 in Leichlingen, Germany (Near Cologne) and attracted approximately 60 participants from all around the world.  It was at the symposium that the concept for the creation of the International institute for Applied Corneotherapy was born.

 

 Some of the delegates who attended the 2nd International Symposium on Corneotherapy 2013
Read more: The 2nd International Corneotherapy Symposium

Company Information

 

International Association for Applied Corneotherapy

The International Association for Applied Corneotherapy (I.A.C.) is a registered, non-profit association with primary purposes and objectives of the advancement of scientific research in the realm of Corneotherapy and related sciences.

 

Executive Team

Board:
Florence Barrett-Hill - New Zealand
Dr. Hans Lautenschlager, Ph.D. - Germany

Secretary:
Margaret Walsh

Scientific Advisory Board:
Assoc. Prof. Dr. Lars Norlén.
Department of Dermatology, University Hospital, Stockholm, Sweden.

Education Commission:
Florence Barrett-Hill
Rene Serbon
Alexandra J. Zani

Language Translation Disclaimer

The Corneotherapy website uses a language translation service. The IAC has made reasonable efforts in order to provide accurate translations, however it is a software translation and as such will not have the accuracy of a manually translated site.

If any questions arise concerning the accuracy of the information presented by the translated version of the website, please refer to the official English version of the website.

Back to top